1. Home
  2. ABCL vs OLED Comparison

ABCL vs OLED Comparison

Compare ABCL & OLED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$13.27

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Logo Universal Display Corporation

OLED

Universal Display Corporation

BUY

Current Price

$79.15

Market Cap

3.6B

Sector

Technology

ML Signal

BUY

Company Overview

Basic Information
Metric
ABCL
OLED
Founded
2012
1985
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.6B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
ABCL
OLED
Price
$13.27
$79.15
Analyst Decision
Strong Buy
Buy
Analyst Count
11
9
Target Price
$16.70
★ $115.37
AVG Volume (30 Days)
★ 4.4M
648.2K
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
★ 2.49%
EPS Growth
★ 10.91
9.25
EPS
N/A
★ 1.82
Revenue
$75,128,000.00
★ $650,611,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.91
$7.94
P/E Ratio
★ N/A
$42.52
Revenue Growth
★ 160.56
0.45
52 Week Low
$2.75
$73.23
52 Week High
$14.98
$153.38

Technical Indicators

Market Signals
Indicator
ABCL
OLED
Relative Strength Index (RSI) 59.09 49.90
Support Level $10.38 $77.02
Resistance Level N/A $94.26
Average True Range (ATR) 0.77 2.26
MACD 0.05 0.33
Stochastic Oscillator 58.85 87.77

Price Performance

Historical Comparison
ABCL
OLED

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About OLED Universal Display Corporation

Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. The Company has one reportable business segment being OLED technologies and materials. The large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.

Share on Social Networks: